News Sentiment

LIVN sentiment intelligence

LivaNova PLC news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 64 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 82.56 Week of 10 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

75/100 classification confidence.

Company focus 53

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

-1.3% over one week, +4.0% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

LIVN Maintains by Mizuho -- Price Target Raised to $95.00

Market Reaction

Balanced read

65/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 75/100 classification
One-week reaction -1.3% Price digesting
Trend fit Trend active 4.0% over four weeks
Fair value 53.3% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 20
Neutral 41
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 53
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Market source 14
TradingView 11
GuruFocus 3
Investing.com 3
simplywall.st 3
www.marketscreener.com 3
Business Wire 3
MSN 2

Event Lens

What the news is about

Classified themes
Market update 27
Earnings 24
Analyst action 5
Guidance 3
Regulatory and legal 2
Balance sheet 1
Macro sensitivity 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 64
GuruFocus Direct company coverage

LIVN Maintains by Mizuho -- Price Target Raised to $95.00

Mizuho analyst Anthony Petrone maintained an Outperform rating for LivaNova (LIVN) and raised the price target to $95.00 from $90.00. This reflects confidence in the company's growth, despite GuruFocus indicating LIVN is currently overvalued with a GF Value™ of $62.61 against a c

Tone
Positive 64/100
Event
Analyst action
Published
15 Jul 2026 19:40
Source
GuruFocus
GuruFocus Direct company coverage

LivaNova PLC (LIVN) Shares Fall 4.7% -- GF Value Says Still Overvalued

LivaNova PLC (LIVN) shares fell 4.7% to $79.13, yet GuruFocus's GF Value still assesses the stock as "Modestly Overvalued" with an estimated intrinsic value of $62.60. Despite a current P/E ratio lower than its historical median, insider selling of $0.2 million with no buying act

Tone
Negative 37/100
Event
Market update
Published
14 Jul 2026 18:43
Source
GuruFocus
MSN Direct company coverage

LivaNova appoints Anne Liddy as chief legal officer

LivaNova has announced the appointment of Anne Liddy as the new chief legal officer. Liddy brings experience from her previous role as global legal head for the cardiovascular, renal, and medical products group at Baxter International, and has held positions at Hillrom and Abbott

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 13:40
Source
MSN
TradingView Direct company coverage

Enterprise value to EBIT forward of LivaNova Plc – SWB:LIA

This article provides financial information for LivaNova Plc (SWB:LIA), specifically focusing on its enterprise value to EBIT forward. The content is presented within the context of TradingView's platform, offering financial data and market insights for the Stuttgart Stock Exchan

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 03:13
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of LivaNova Plc – SWB:LIA

This article provides financial information for LivaNova Plc (SWB:LIA), specifically focusing on its Price to Earnings Forward metric. The content, presented by TradingView, is part of a larger financial data service, indicating no specific data points but rather a static page fo

Tone
Neutral 50/100
Event
Earnings
Published
10 Jul 2026 02:39
Source
TradingView
TradingView Direct company coverage

Price to sales forward of LivaNova PLC – NASDAQ:LIVN

This article provides the "Price to sales forward" metric for LivaNova PLC (NASDAQ: LIVN) on TradingView. It indicates that the market is closed and no trades have occurred for this specific metric. The content is presented within the context of TradingView's financial analysis t

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 07:13
Source
TradingView
AD HOC NEWS Direct company coverage

LivaNova PLC balances neuromodulation growth with cardiac surgery challenges

LivaNova PLC focuses on expanding its neuromodulation solutions for neurological disorders while maintaining its core presence in cardiac surgery devices. The company balances investments between these two areas, with neuromodulation offering higher growth potential and cardiac s

Tone
Neutral 50/100
Event
Market update
Published
08 Jul 2026 17:18
Source
AD HOC NEWS
Stock Traders Daily Direct company coverage

(LIVN) as a Liquidity Pulse for Institutional Tactics

This article provides an in-depth AI-driven analysis for Livanova Plc (NASDAQ: LIVN), highlighting strong sentiment across all horizons supporting an overweight bias. It outlines detailed institutional trading strategies, including position trading, momentum breakout, and risk he

Tone
Positive 81/100
Event
Balance sheet
Published
08 Jul 2026 15:06
Source
Stock Traders Daily
TradingView Direct company coverage

Price to book forward of LivaNova PLC – NASDAQ:LIVN

This article provides financial data for LivaNova PLC (NASDAQ: LIVN), specifically its price-to-book forward ratio. It is a brief financial snippet from TradingView, offering current valuation metrics for the company.

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 17:39
Source
TradingView
TipRanks Direct company coverage

LivaNova Stock Sinks After Key Sleep Trial Fails

LivaNova PLC's stock is falling after its OSPREY clinical trial for the aura6000 sleep apnea device failed to achieve its primary efficacy goal, leading to the study's discontinuation. This setback eliminates a significant growth opportunity for LivaNova and concerns investors ab

Tone
Negative 19/100
Event
Market update
Published
07 Jul 2026 17:39
Source
TipRanks
TradingView Direct company coverage

Enterprise value to EBITDA forward of LivaNova PLC – NASDAQ:LIVN

This article focuses on the enterprise value to EBITDA forward for LivaNova PLC (NASDAQ: LIVN) as presented on TradingView. It appears to be a financial data snippet from a larger platform, indicating the company's financial metrics under the "Financials" section. The document pr

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 14:11
Source
TradingView
AD HOC NEWS Direct company coverage

LivaNova PLC focuses on neuromodulation and cardiopulmonary solutions as investors track its Nasdaq-listed stock

LivaNova PLC (LIVN) is a global medical technology company listed on Nasdaq, specializing in medical devices for cardiovascular care and neuromodulation therapy. The company's long-term growth is driven by demand for life-saving procedures and chronic disease management, with a f

Tone
Positive 67/100
Event
Macro sensitivity
Published
07 Jul 2026 12:11
Source
AD HOC NEWS
TradingView Direct company coverage

Price to sales forward of LivaNova Plc – LSX:A14156

This article displays the "Price to sales forward" metric for LivaNova Plc (LSX:A14156) on TradingView. It appears to be a financial data snippet from the platform, showing basic company information and navigation to various financial tools and community features.

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 08:11
Source
TradingView
Simply Wall Street Direct company coverage

How LivaNova’s Broad Russell Index Inclusion Will Impact LivaNova (LIVN) Investors

LivaNova PLC (NasdaqGS:LIVN) was recently added to several Russell growth and small-cap indexes, including the Russell 2000 Growth-Defensive Index and Russell 3000 Growth Benchmark. This inclusion is expected to increase the company's visibility among institutional investors but

Tone
Positive 63/100
Event
Market update
Published
07 Jul 2026 05:10
Source
Simply Wall Street
TradingView Direct company coverage

Enterprise value to EBIT forward of LivaNova Plc – DUS:LIA

This article provides financial information for LivaNova Plc (DUS:LIA) including its Enterprise Value to EBIT forward metric. The content appears to be a stub or a section of a larger financial data page from TradingView, displaying various navigation and informational links rela

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 23:41
Source
TradingView
Investing.com Direct company coverage

LivaNova stock hits 52-week high at 84.3 USD

LivaNova PLC's stock reached a new 52-week high of $84.30, demonstrating an 81% total return over the past year. The company also announced promising data from its PolySync algorithm for sleep apnea and made several strategic leadership appointments and board additions. Investing

Tone
Positive 74/100
Event
Market update
Published
06 Jul 2026 13:40
Source
Investing.com
Medical Product Outsourcing Direct company coverage

LivaNova Shares Positive 12-Month Results From Obstructive Sleep Apnea Study

LivaNova Plc announced positive 12-month results from its OSPREY randomized controlled trial (RCT) for the aura6000 System, demonstrating the safety and efficacy of proximal hypoglossal nerve stimulation (pHGNS) in treating moderate to severe obstructive sleep apnea (OSA). The st

Tone
Positive 91/100
Event
Earnings
Published
30 Jun 2026 16:10
Source
Medical Product Outsourcing
www.marketscreener.com Direct company coverage

LivaNova PLC(NasdaqGS: LIVN) added to Russell Small Cap Comp Growth Benchmark

LivaNova PLC (NasdaqGS: LIVN), a medical technology company specializing in cardiopulmonary and neuromodulation products, has been added to the Russell Small Cap Comp Growth Benchmark. This inclusion was formalized on June 29, 2026, alongside its addition to several other Russell

Tone
Positive 68/100
Event
Market update
Published
29 Jun 2026 21:09
Source
www.marketscreener.com
www.marketscreener.com Direct company coverage

LivaNova PLC(NasdaqGS: LIVN) added to Russell 2000 Growth Benchmark

LivaNova PLC (NasdaqGS: LIVN), a medical technology company, has been added to the Russell 2000 Growth Benchmark. The company designs, develops, manufactures, markets, and sells products and therapies across its Cardiopulmonary and Neuromodulation segments. This inclusion highlig

Tone
Positive 73/100
Event
Market update
Published
29 Jun 2026 10:43
Source
www.marketscreener.com
www.marketscreener.com Direct company coverage

LivaNova PLC(NasdaqGS: LIVN) added to Russell 3000 Growth Benchmark

LivaNova PLC (NasdaqGS: LIVN) was added to the Russell 3000 Growth Benchmark on June 28, 2026. The company is a medical technology firm specializing in cardiopulmonary and neuromodulation products and therapies. LivaNova has also been added to other Russell benchmarks, including

Tone
Positive 72/100
Event
Market update
Published
29 Jun 2026 04:09
Source
www.marketscreener.com
Stock Traders Daily Direct company coverage

(LIVN) Risk Channels and Responsive Allocation

This article analyzes Livanova Plc (LIVN) using AI models, identifying strong sentiment across all horizons supporting an overweight bias. It provides institutional trading strategies, including position trading, momentum breakout, and risk hedging, along with multi-timeframe sig

Tone
Positive 71/100
Event
Market update
Published
27 Jun 2026 14:10
Source
Stock Traders Daily
TradingView Direct company coverage

Livanova PLC Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh

This page provides financial actuals and estimates for Livanova PLC Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh (L2IV34) traded on BMFBOVESPA. Users can explore reported financial data and analyst estimates for income statements, balance sheets, cash flow statement

Tone
Neutral 50/100
Event
Analyst action
Published
27 Jun 2026 05:39
Source
TradingView
TradingView Direct company coverage

LivaNova Plc Actuals & Estimates (NASDAQ:LIVN)

This article provides an overview of LivaNova PLC (NASDAQ: LIVN) stock, including its current price, performance, and analyst forecasts. It details financial actuals and estimates for the company's income statement, balance sheet, and cash flow, alongside answers to frequently as

Tone
Positive 67/100
Event
Analyst action
Published
26 Jun 2026 20:39
Source
TradingView
TradingView Direct company coverage

LIVN Forecast — Price Target — Prediction for 2027

This article provides a forecast for LivaNova PLC (LIVN) stock, including analyst price targets, historical stock performance, and expected earnings and revenue. It details the current stock price, market capitalization, and key financial metrics, while also addressing frequently

Tone
Positive 77/100
Event
Earnings
Published
26 Jun 2026 13:43
Source
TradingView
Investing.com South Africa Direct company coverage

LivaNova stock hits 52-week high at 81.08 USD By Investing.com

LivaNova PLC's stock reached a new 52-week high of $81.08, reflecting a 74% increase over the past year. The company's recent Q1 2026 earnings surpassed analyst expectations, and it has announced strategic leadership changes. InvestingPro analysis suggests the stock, currently tr

Tone
Positive 87/100
Event
Earnings
Published
26 Jun 2026 12:39
Source
Investing.com South Africa